On traditional Chinese medicine clinical trials

Drug Information Journal

Volumn 40, Issue 4, 2006, Pages 395-406

  Chow, Shein Chung ^a   Pong, Annpey ^b   Chang, Yu Wei ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EISAI INC   (United States)

^c Taiwan Carol Electronics Co Ltd   (Taiwan)

Author keywords

Calibration; Flexible dose; Global balance harmony; Multiple components; Test for consistency; Validation

Indexed keywords

CHINESE DRUG;

ARTICLE; CALIBRATION; CHINESE MEDICINE; CLINICAL RESEARCH; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG RESEARCH; DRUG SAFETY; DRUG STABILITY; EXPIRATION DATE; HUMAN; MEDICAL PRACTICE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLE SIZE; THEORY; UNSPECIFIED SIDE EFFECT; VALIDATION PROCESS; WESTERN HEMISPHERE;

EID: 33750847747     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/216847900604000404     Document Type: Article

References (22)

1. Chow SC, Liu JP. Design and Analysis of Clinical Trials. New York: John Wiley and Sons; 2000.
2. Guilford JP. Psychometric Methods. 2nd ed. New York: McGraw-Hill; 1954.
3. Guyatt GH, Veldhuyen Van Zanten SJO, Feeny DH, Patric DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J. 1989;140:1441-1448.
4. Hollenberg NK, Testa M, Williams GH. Quality of life as a therapeutic end-point - an analysis of therapeutic trials in hypertenson. Drug Safety. 1991;6:83-93.
5. Chow SC, Ki F. On statistical characteristics of quality of life assessment. J Biopharm Stat. 1994;4:1-17.
6. Chow SC, Ki F. Statistical issues in quality of life assessment. J Biopharm Stat. 1996;6:37-48.
7. Chow SC, Shao J. Statistics in Drug Research-Methodologies and Recent Development. New York: Marcel Dekker; 2002.
8. Hsiao CF, Tsou HH, Pong A, Liu P, Lin CH, Chow SC. Statistical validation of traditional Chinese diagnostic procedure. Submitted.
9. Chow SC, Shao J, Wang H. Sample Size Calculation in Clinical Research. New York: Marcel Dekker; 2002.
10. Chow SC, Liu JP. Statistical Design and Analysis in Pharmaceutical Science. New York: Marcel Dekker; 1995.
11. Tse SK, Chang JY, Su WL, Chow SC, Hsiung C, Lu Q. Statistical quality control process for traditional Chinese medicine. J Biopharm Stat. 2006; 16: in press.
12. PDR. Physicians' Desk Reference for Herbal Medicines. Montvale, NJ: Medical Economics Company; 1998.
13. Food and Drug Administration. Guideline for Submitting Documentation for the Stability of Human Drugs and Biologics. Rockville, MD: Center for Drugs and Biologics, Office of Drug Research and Review, Food and Drug Administration; 1987.
14. International Conference on Harmonisation. Validation of Analytical Procedures: Methodology. Tripartite International Conference on Harmonization Guideline. Geneva, Switzerland: International Conference on Harmonisation; 1996.
15. Pong A, Raghavarao D. Comparing distributions of drug shelf lives for two components in stability analysis for different designs. J Biopharm Stat. 2002;12:277-293.
16. Chow SC, Shao J. Stability analysis for drugs with multiple active ingredients. Stat Med. 2006;25: in press.
17. Ministry of Public Health . Guidance for Drug Registration. Beijing, China: Ministry of Public Health; 2002.
18. Department of Health. Draft Guidance for IND of Traditional Chinese Medicine. Taipei, Taiwan: Department of Health; 2004.
19. Department of Health. Draft Guidance for NDA of Traditional Chinese Medicine. Taipei, Taiwan: Department of Health; 2004.
20. Food and Drug Administration. Guidance for Industry-Botanical Drug Products. Rockville, MD: US Food and Drug Administration; 2004.
21. Food and Drug Administration. Guidance for In Vivo Bioequivalence and In Vitro Drug Release. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration; 1991.
22. Liu JP, Chow SC. Statistical issues on FDA conjugated estrogen tablets guideline. Drug Inf J. 1996;30:881-889.